Page last updated: 2024-08-24

isobutyramide and losartan potassium

isobutyramide has been researched along with losartan potassium in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bianchi, P; Cappellini, MD; Ciceri, L; Comino, A; Fiorelli, G; Graziadei, G; Pomati, M	1
Bührer, C; Henze, G; Kage, A; Kulozik, AE; Mesche, M; Müller, C; Ohlendorf, D; Reich, S; Sinha, P; Vetter, B	1

Trials

1 trial(s) available for isobutyramide and losartan potassium

Article	Year
Butyrate trials. Annals of the New York Academy of Sciences, 1998, Jun-30, Volume: 850 Topics: Adult; Amides; beta-Thalassemia; Blood Transfusion; Erythropoietin; Female; Fetal Hemoglobin; Globins; Humans; Male; Receptors, Transferrin	1998

Other Studies

1 other study(ies) available for isobutyramide and losartan potassium

Article	Year
Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia. Blood, 2000, Nov-15, Volume: 96, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Amides; Antineoplastic Agents; beta-Thalassemia; Blood; Blood Transfusion; Child; Child, Preschool; Drug Evaluation; Erythrocyte Indices; Erythropoietin; Female; Fetal Hemoglobin; Genotype; Hemoglobins; Hemolysis; Homozygote; Humans; Iron; Longitudinal Studies; Male; Patient Compliance; Time Factors	2000

Article

Year

Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia.

Blood, 2000, Nov-15, Volume: 96, Issue:10

Topics: Administration, Oral; Adolescent; Adult; Amides; Antineoplastic Agents; beta-Thalassemia; Blood; Blood Transfusion; Child; Child, Preschool; Drug Evaluation; Erythrocyte Indices; Erythropoietin; Female; Fetal Hemoglobin; Genotype; Hemoglobins; Hemolysis; Homozygote; Humans; Iron; Longitudinal Studies; Male; Patient Compliance; Time Factors

2000